American Oncology Network, LLC (AON) is pleased to announce that Cancer and Blood Specialists of NOVA, a leading community oncology and hematology practice serving Northern Virginia, has joined AON.
Fort Myers, Fla., May 4, 2020—American Oncology Network, LLC (AON) is pleased to announce that Cancer and Blood Specialists of NOVA, a leading community oncology and hematology practice serving Northern Virginia, has joined AON, effective May 1, 2020.
Cancer and Blood Specialists of NOVA has been providing comprehensive, state-of-the-art treatment for patients diagnosed with cancer and blood disorders at its clinic in the Washington D.C. Metropolitan area since 1987. The practice was founded by Medical Oncologist and Hematologist Dr. Masoom Kandahari. Dr. Kandahari is currently joined by Medical Oncologist and Hematologist Dr. Farn Chan and a nurse practitioner.
“We are excited to have Drs. Kandahari and Chan join AON,” said AON CEO Brad Prechtl, MBA. “Cancer and Blood Specialists of NOVA will continue to offer the highest level of cancer care with enhanced services such as home delivery for oral oncolytic medications and centralized laboratory and pathology services for quicker results.”
“This partnership with AON and the Cancer and Blood Specialists of NOVA will help drive change in community cancer care with access to advanced technologies and the latest treatment options for Virginia patients,” said AON Board Member & Chairman Dr. Stephen Orman.
Read the full press release here.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More